Prostate cancer is the second leading cause of cancer deaths in males, and combined with benign prostatic hyperplasia (BPH), represents the leading neoplastic disease in men. In humans, the prostate gland has the unique function of producing and secreting extraordinarily high levels of citrate. These physiology functions of the prostate are regulated by testosterone and prolactin. The lost of the capability to produce citric acid is a characteristic of prostate cancer and is among the first metabolic changes associated with the development of prostate malignancy. Glandular BPH on the other hand is characterized by excessive proliferation of citrate producing secretory epithelial cells and thus an even higher level of citrate that the normal gland. The two key enzymes directly involved in citrate synthesis by prostate epithelial cells are mitochondrial aspartate aminotransferase (mAAT) and pyruvate dehydrogenase (PDH). Both of these enzymes are regulated by testosterone and prolactin. The broad objectives of this grant application are to elucidate the mechanisms by which prolactin regulates expression and activity of these intermediary metabolic enzymes; to elucidate the intracellular signaling pathways involved and to use this information to develop new approaches to the diagnosis, prevention, and treatment of prostate neoplastic disease. The general hypotheses of this grant application are: The mAAT and E1a genes contain a TPA response element (TPA) that is responsible for prolactin regulation of expression via PKC; that the cell specificity of this regulation is achieved by prolactin activation of specific PKC isoforms (particularly PKC epsilon) which activate selective transcription factors (particularly AP-I); and that prolactin increases the active form of E1a which increases pyruvate oxidation.
The specific aims proposed to test these hypotheses are (l) to establish that PKC epsilon and activator protein-I (AP-l) mediate prolactin regulation of mAAT and PDHE1 alpha expression; (2) to determine if prolactin increases pyruvate oxidation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK042839-12
Application #
6634968
Study Section
Reproductive Endocrinology Study Section (REN)
Program Officer
Mullins, Christopher V
Project Start
1992-03-01
Project End
2005-06-30
Budget Start
2003-07-01
Budget End
2005-06-30
Support Year
12
Fiscal Year
2003
Total Cost
$244,918
Indirect Cost
Name
University of Maryland Baltimore
Department
Dentistry
Type
Schools of Dentistry
DUNS #
188435911
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Costello, Leslie C (2018) Poor Science; Poorly Trained Scientists; Poor Policies: Major Deterrents to the War on Cancer. J Can Res Updates 7:79-83
Costello, Leslie C; Franklin, Renty B (2017) Decreased zinc in the development and progression of malignancy: an important common relationship and potential for prevention and treatment of carcinomas. Expert Opin Ther Targets 21:51-66
Franklin, Renty B; Zou, Jing; Zheng, Yao et al. (2016) Zinc Ionophore (Clioquinol) Inhibition of Human ZIP1-Deficient Prostate Tumor Growth in the Mouse Ectopic Xenograft Model: A Zinc Approach for the Efficacious Treatment of Prostate Cancer. Int J Cancer Clin Res 3:
Costello, Leslie C; Franklin, Renty B (2016) A comprehensive review of the role of zinc in normal prostate function and metabolism; and its implications in prostate cancer. Arch Biochem Biophys 611:100-112
Costello, Leslie C; Zou, Jing; Franklin, Renty B (2016) In situ clinical evidence that zinc levels are decreased in breast invasive ductal carcinoma. Cancer Causes Control 27:729-35
Costello, Leslie C; Franklin, Renty B; Zou, Jing et al. (2015) Evidence that Human Prostate Cancer is a ZIP1-Deficient Malignancy that could be Effectively Treated with a Zinc Ionophore (Clioquinol) Approach. Chemotherapy (Los Angel) 4:
Franklin, Renty B; Zou, Jing; Costello, Leslie C (2014) The cytotoxic role of RREB1, ZIP3 zinc transporter, and zinc in human pancreatic adenocarcinoma. Cancer Biol Ther 15:1431-7
Costello, Leslie C; Franklin, Renty B (2014) The status of zinc in the development of hepatocellular cancer: an important, but neglected, clinically established relationship. Cancer Biol Ther 15:353-60
Costello, Leslie C; Franklin, Renty B (2013) A Review of the Current Status and Concept of the Emerging Implications of Zinc and Zinc Transporters in the Development of Pancreatic Cancer. Pancreat Disord Ther Suppl 4:
Costello, Leslie C; Franklin, Renty B (2013) A review of the important central role of altered citrate metabolism during the process of stem cell differentiation. J Regen Med Tissue Eng 2:

Showing the most recent 10 out of 37 publications